Unknown

Dataset Information

0

Identification of novel N-(morpholine-4-carbonyloxy) amidine compounds as potent inhibitors against hepatitis C virus replication.


ABSTRACT: To identify novel compounds that possess antiviral activity against hepatitis C virus (HCV), we screened a library of small molecules with various amounts of structural diversity using an HCV replicon-expressing cell line and performed additional validations using the HCV-JFH1 infectious-virus cell culture. Of 4,004 chemical compounds, we identified 4 novel compounds that suppressed HCV replication with 50% effective concentrations of ranging from 0.36 to 4.81 μM. N'-(Morpholine-4-carbonyloxy)-2-(naphthalen-1-yl) acetimidamide (MCNA) was the most potent and also produced a small synergistic effect when used in combination with alpha interferon. Structure-activity relationship (SAR) analyses revealed 4 derivative compounds with antiviral activity. Further SAR analyses revealed that the N-(morpholine-4-carbonyloxy) amidine moiety was a key structural element for antiviral activity. Treatment of cells with MCNA activated nuclear factor κB and downstream gene expression. In conclusion, N-(morpholine-4-carbonyloxy) amidine and other related morpholine compounds specifically suppressed HCV replication and may have potential as novel chemotherapeutic agents.

SUBMITTER: Kusano-Kitazume A 

PROVIDER: S-EPMC3294916 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4329992 | biostudies-literature
| S-EPMC9731315 | biostudies-literature
| S-EPMC10556424 | biostudies-literature
| S-EPMC3859510 | biostudies-literature
| S-EPMC6136245 | biostudies-literature
| S-EPMC4589464 | biostudies-literature
| S-EPMC2043288 | biostudies-literature
| S-EPMC4027583 | biostudies-literature
| S-EPMC4893694 | biostudies-other
| S-EPMC6256752 | biostudies-literature